0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Clinically Relevant Resistance in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 2002) Loot Price: R2,905
Discovery Miles 29 050
Clinically Relevant Resistance in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 2002): Borje...

Clinically Relevant Resistance in Cancer Chemotherapy (Paperback, Softcover reprint of the original 1st ed. 2002)

Borje Andersson, David Murray

Series: Cancer Treatment and Research, 112

 (sign in to rate)
Loot Price R2,905 Discovery Miles 29 050 | Repayment Terms: R272 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Cancer Treatment and Research, 112
Release date: October 2012
First published: 2002
Editors: Borje Andersson • David Murray
Dimensions: 235 x 155 x 21mm (L x W x T)
Format: Paperback
Pages: 380
Edition: Softcover reprint of the original 1st ed. 2002
ISBN-13: 978-1-4613-5428-4
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 1-4613-5428-5
Barcode: 9781461354284

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Cancer: A Love Story - Memoir Of A…
Lauren Segal Paperback  (1)
R360 Discovery Miles 3 600
Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,773 Discovery Miles 47 730
Encyclopedia of Infection and Immunity
Nima Rezaei Hardcover R62,178 Discovery Miles 621 780
Immunotherapy in Resistant Cancer: From…
Jorge Morales Montor, Mariana Segovia Hardcover R3,725 Discovery Miles 37 250
Sphingolipids in Cancer, Volume 140
Charles E. Chalfant, Paul B. Fisher Hardcover R3,977 Discovery Miles 39 770
Lung Cancer, An Issue of…
Roy S. Herbst, Daniel Morgensztern Hardcover R2,256 Discovery Miles 22 560
Adjunctive Rehabilitation Approaches to…
Andrea L. Cheville Hardcover R2,257 Discovery Miles 22 570
Pediatric Brain Tumors Update, An Issue…
Lara Brandao Hardcover R2,274 Discovery Miles 22 740
Neuroendocrine Tumors, An Issue of…
Jennifer Chan, Matthew Kulke Hardcover R1,799 Discovery Miles 17 990
Geriatric Oncology, An Issue of Clinics…
Harvey J. Cohen, Arati V Rao Hardcover R1,796 Discovery Miles 17 960
Pulmonary Metastasectomy, An Issue of…
Mark W Onaitis, Thomas A. D'Amico Hardcover R2,658 Discovery Miles 26 580
Testicular Cancer, An Issue of Urologic…
Daniel W. Lin Hardcover R1,800 Discovery Miles 18 000

See more

Partners